Literature DB >> 8935468

Tobacco use prevalence and correlates among adolescents in a clinician initiated tobacco prevention trial in California, USA.

M F Hovell1, D J Slymen, K J Keating, J A Jones, S Burkham-Kreitner, C R Hofstetter, D Noel, B Rubin.   

Abstract

OBJECTIVES: Baseline data for the clinician initiated, tobacco prevention trial, the first non-school based clinician mediated tobacco prevention study, were used to explore the degree to which young people receiving orthodontic treatment use tobacco and the differences in use rates between national, California, and patient samples. Correlates of tobacco use were identified and these correlates were contrasted with findings from the published reports. DESIGN AND
SETTING: A 26 item telephone survey assessed demographic information, tobacco use, selected health related behaviours, and variables based on social learning theory. The study was conducted among 11 to 18 year old orthodontic patients from San Diego, Orange, Riverside, San Bernardino, and Los Angeles Counties, California, USA. PARTICIPANTS: Of the 17925 patients who were eligible, 16915 (> 94%) completed the survey.
MEASUREMENTS AND MAIN RESULTS: Multivariate analyses were conducted using a logistic mixed effects model. Although the 30 day prevalence rate of tobacco use (6%, n = 1010) proved lower than California and national samples, the rates for the age, gender, and race ethnicity subgroups showed trends similar to those seen in California and national samples. Ten variables were significantly associated with tobacco use (p < 0.05), including 30 day alcohol use (OR = 7.88), age (OR = 1.32), and living with a tobacco user (OR = 1.72).
CONCLUSIONS: Because 6% of orthodontic patients use tobacco, interventions are warranted to reach the health "Objectives for the Nation". Patterns of correlates of tobacco use were essentially the same for orthodontic patients, California, and national samples, suggesting that these associations are generalisable.

Entities:  

Mesh:

Year:  1996        PMID: 8935468      PMCID: PMC1060293          DOI: 10.1136/jech.50.3.340

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  20 in total

1.  Adolescent drug use: findings of national and local surveys.

Authors:  E R Oetting; F Beauvais
Journal:  J Consult Clin Psychol       Date:  1990-08

2.  Risk factors for adolescent cigarette smoking. The Muscatine study.

Authors:  T M Reimers; P R Pomrehn; S L Becker; R M Lauer
Journal:  Am J Dis Child       Date:  1990-11

Review 3.  Physician-initiated smoking cessation program: the National Cancer Institute trials.

Authors:  T J Glynn; M W Manley; T F Pechacek
Journal:  Prog Clin Biol Res       Date:  1990

4.  Explanation of vigorous physical activity during two years using social learning variables.

Authors:  J F Sallis; M F Hovell; C R Hofstetter; E Barrington
Journal:  Soc Sci Med       Date:  1992-01       Impact factor: 4.634

5.  Quitting smoking in the United States in 1986.

Authors:  E J Hatziandreu; J P Pierce; M Lefkopoulou; M C Fiore; S L Mills; T E Novotny; G A Giovino; R M Davis
Journal:  J Natl Cancer Inst       Date:  1990-09-05       Impact factor: 13.506

Review 6.  Adolescent smoking: research and health policy.

Authors:  P D Cleary; J L Hitchcock; N Semmer; L J Flinchbaugh; J M Pinney
Journal:  Milbank Q       Date:  1988       Impact factor: 4.911

7.  Cultural diversity in the predictors of adolescent cigarette smoking: the relative influence of peers.

Authors:  H Landrine; J L Richardson; E A Klonoff; B Flay
Journal:  J Behav Med       Date:  1994-06

Review 8.  Cigarette smoking: the clinician's role in cessation, prevention, and public health.

Authors:  M C Fiore; J P Pierce; P L Remington; B J Fiore
Journal:  Dis Mon       Date:  1990-04       Impact factor: 3.800

Review 9.  The clinician's role in preventing smoking initiation.

Authors:  R P Epps; M W Manley
Journal:  Med Clin North Am       Date:  1992-03       Impact factor: 5.456

10.  Effect of general practitioners' advice against smoking.

Authors:  M A Russell; C Wilson; C Taylor; C D Baker
Journal:  Br Med J       Date:  1979-07-28
View more
  7 in total

1.  Predictors of cigarette smoking and smoking cessation among adults with asthma.

Authors:  M D Eisner; E H Yelin; P P Katz; S C Shiboski; J Henke; P D Blanc
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

2.  A simulation of the effects of youth initiation policies on overall cigarette use.

Authors:  D T Levy; K M Cummings; A Hyland
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

3.  An adolescent tobacco-use prevention trial in orthodontic offices.

Authors:  M F Hovell; D J Slymen; J A Jones; C R Hofstetter; S Burkham-Kreitner; T L Conway; B Rubin; D Noel
Journal:  Am J Public Health       Date:  1996-12       Impact factor: 9.308

4.  Proactive recruitment predicts participant retention to end of treatment in a secondhand smoke reduction trial with low-income maternal smokers.

Authors:  Bradley N Collins; E Paul Wileyto; Melbourne F Hovell; Uma S Nair; Karen Jaffe; Natalie M Tolley; Janet Audrain-McGovern
Journal:  Transl Behav Med       Date:  2011-09       Impact factor: 3.046

5.  Secondhand smoke avoidance by preteens living with smokers: to leave or stay?

Authors:  Ding Ding; Dennis R Wahlgren; Sandy Liles; Jennifer A Jones; Suzanne C Hughes; Melbourne F Hovell
Journal:  Addict Behav       Date:  2010-06-22       Impact factor: 3.913

6.  Parent quit attempts after counseling to reduce children's secondhand smoke exposure and promote cessation: main and moderating relationships.

Authors:  Sandy Liles; Melbourne F Hovell; Georg E Matt; Joy M Zakarian; Jennifer A Jones
Journal:  Nicotine Tob Res       Date:  2009-10-29       Impact factor: 4.244

7.  Risk factors for tobacco susceptibility in an orthodontic population: An exploratory study.

Authors:  Jared Michael Jashinsky; Sandy Liles; Katy Schmitz; Ding Ding; Melbourne Hovell
Journal:  Am J Orthod Dentofacial Orthop       Date:  2017-08       Impact factor: 2.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.